Research Leaders Across New York State Form Empire State Cellular Therapy Consortium

To expand on early progress in the emerging field of cell and gene therapy, five research centers across New York State are collaborating to develop new cell therapies for cancer and other diseases.

By
July 29, 2025
7 min

Roswell Park Comprehensive Cancer Center

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

#1

Roswell Park Comprehensive Cancer Center

Buffalo, NY
Key Differentiators
- Cell and Gene Therapy
- Cancer Immunotherapy
- Translational Research
#2

The Icahn School of Medicine at Mount Sinai

New York, NY
Key Differentiators
- Cell and Gene Therapy
- Immunotherapy
- Neurological Disorders
#3

NYU Langone Health

New York, NY
Key Differentiators
- Cell and Gene Therapy
- Cancer Research
- Immunotherapy
#4

Weill Cornell Medicine

New York, NY
Key Differentiators
- Cell and Gene Therapy
- Cancer Immunotherapy
- Translational Medicine
#5

University of Rochester Wilmot Cancer Institute

Rochester, NY
Key Differentiators
- Cell and Gene Therapy
- Cancer Research
- Immunotherapy

Research Leaders Across New York State Form Empire State Cellular Therapy Consortium

Top Institutions in Hematology

Roswell Park Comprehensive Cancer Center

The Icahn School of Medicine at Mount Sinai

NYU Langone Health

Weill Cornell Medicine

University of Rochester Wilmot Cancer Institute

Original Source(s)

Research Leaders Across New York State Form Empire State Cellular Therapy Consortium

Related Content

miR-142-5p promotes TSCM differentiation and suppresses progressive T-cell maturation via targeting PRKCB

Ultra-high-sensitivity next-generation sequencing–based MRD predicts outcome in intensively treated older patients with acute myeloid leukemia: results from the ALFA-1200 cohort

Designing universal T cell therapies: strategies to evade natural killer cells